Estimauville life sciences hub

A cutting-edge environment dedicated to scientific advances, applied research, and technological development.
Formerly known as Medicago, the building was originally designed for the production of 40 to 50 million doses of seasonal influenza vaccines, and also housed corporate offices alongside research and development operations.

The building has since changed hands and purpose. It is now positioned as a life sciences hub, designed to foster a world-class environment dedicated to scientific and technological advancement, and to meet the growing needs of the health and life sciences sectors. The facility will offer modern, flexible, and highly specialized infrastructure — built to drive innovation, applied research, and high-value industrial development.

In scale and ambition, the project will actively strengthen the life sciences ecosystem of the Quebec City region, elevating its profile as a centre of excellence in life sciences and health technologies on both a national and international stage.

Conceived to accommodate a broad range of uses, the building will support diverse scientific, industrial, and technological activities, while encouraging collaboration among the key players driving innovation forward.